Read more

December 13, 2023
3 min watch
Save

VIDEO: ‘Unique’ protocol expands transplant pool to include HCV-infected donors

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, spoke with Healio about a presentation from The Liver Meeting on “The Toronto Protocol,” an ultra-short course of glecaprevir/pibrentasvir with ezetimibe.

According to Terrault, the 7-day protocol is designed to prevent chronic hepatitis C virus infection when transplanting solid organs from HCV-infected donors to noninfected recipients.

“That combination is successful in preventing infection in these solid organ transplants of kidney, heart and liver,” Terrault, professor of medicine, chief of gastroenterology and liver diseases, and Neil Kaplowitz Endowed Chair in Liver Diseases Research at the University of Southern California Keck School of Medicine, told Healio. “That is also a very unique, important and cost-effective approach to expanding the donor pool and potentially having more patients receive organs rather than having these organs not be used.”